Laura Brege, Director at ACADIA PHARMACEUTICALS INC (ACAD), sold 14,285 shares at $22.54 ($322K) on 2014-04-04, disclosed to the SEC on 2014-04-04.
Scheduled sale ($322k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PCRX | BUY | 2024-08-19 | $13K | — | Filing → |
| ACAD | SELL | 2023-06-14 | $112K | — | Filing → |
| PCRX | SELL | 2023-06-07 | $23K | — | Filing → |